A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular Administration in Healthy Volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This proof-of-concept study evaluates the clinical efficacy and safety of DCN01 in prepping of the periocular region.
Epistemonikos ID: c67d1f046aec72e4c8df513606e693fec4310e1a
First added on: May 11, 2024